Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Publications
  • Media
  • Contact

Renal/hepatic

Product Candidate

BasicMin Plus

The body’s pH level is crucial for maintaining health and preventing disease. The pH scale ranges from zero to 14, with seven being neutral. A pH below seven is considered acidic, while a pH above seven is considered alkaline. The ideal pH range for the human body is slightly alkaline, with a pH level between 7.35 and 7.45. When the pH level in the body is too acidic, it can lead to various health issues, such as fatigue, headaches, digestive problems, and even chronic diseases like osteoporosis and cancer.

BasicMin Plus is a nutritional supplement specifically formulated to support a normal acid-base balance in the body. Each daily supplement dose contains 450 mg of potassium, 400 mg of calcium (as calcium citrate), and 200 mg of magnesium, nettle (Urtica dioica), and alfalfa (Medicago sativa). The minerals in the supplement synergize to support healthy pH levels and acid-base balance. Nettle and alfalfa are two natural alkalizers that synergistically may help neutralize excess acid in the body. BasicMin Plus is free from unnecessary additives, preservatives, and allergens. It is unlikely to cause adverse effects in healthy individuals when used as recommended. However, individuals who are pregnant, nursing, have a medical condition, or are taking medication should consult with their healthcare provider before taking any dietary supplement, including BasicMin Plus.

Combining iron succinate with BasicMin Plus ensures the body receives a balanced intake of essential minerals. While iron succinate addresses iron deficiency, BasicMin Plus supports overall mineral health and pH balance, improving metabolic function and vitality.

Related product
Ostecibum

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS